IBAB Ion Beam Applications SA

18.03USD16.40 EUR · EBR+0.49%Mkt Cap: 520.95M USDP/E: 19.90

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates …

Institutional holders10 on file

Key Statistics

Company
Market Cap520.95M USD
Enterprise Value609.66M USD
Revenue (TTM)702.39M USD
Gross Profit219.42M USD
Net Income (TTM)13.99M USD
Revenue/Share23.92 USD
Last Price18.03 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.3K
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0003766806
Valuation
P/E (Trailing)19.90
P/E (Forward)14.78
PEG—
EV/EBITDA11.88
EV/Revenue0.87
P/S0.74
P/B4.02
EPS (TTM)0.90 USD
EPS (Forward)1.21 USD
52W Range
10.9882% of range19.52
52W High19.52 USD
52W Low10.98 USD
Profitability
Gross Margin32.19%
Oper. Margin6.35%
EBITDA Margin7.30%
Profit Margin2.05%
ROE10.01%
ROA1.84%
ROIC8.42%
ROCE10.19%
Growth
Revenue Growth6.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.21M USD
CapEx (TTM)13.96M USD
FCF Margin2.50%
FCF Yield3.37%
Net Debt82.41M USD
Net Debt/EBITDA1.61
Net Debt/FCF4.69
Balance Sheet
Debt/Equity0.92
Current Ratio0.99
Quick Ratio0.58
Book Value/Sh4.46 USD
Cash/Share1.64 USD
Dividends
Fwd Div Rate0.27 USD
Trail. Div Rate0.27 USD
Div. Yield1.51%
5Y Avg Yield1.46%
Payout Ratio30.67%
Ex-Div DateJun 15, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)19.37 USD
Upside (mean)+7.5%
Target Range13.19 USD – 22.53 USD
13.19+7.5% to mean22.53
# Analysts4
Ownership
Shares Out.29.04M
Float26.16M
Insiders36.61%
Institutions21.17%
Technical
SMA 5017.51 (+3.0%)
SMA 20017.01 (+6.0%)
Beta1.23
S&P 52W Chg12.00%
Avg Vol (30d)14.90K
Avg Vol (10d)18.55K
Technical Indicators
RSI (14)49.8
MACD0.1678
MACD Signal0.1920
MACD Hist.-0.0242
BB Upper18.77 USD
BB Middle18.04 USD
BB Lower17.32 USD
BB Width8.07%
ATR (14)0.5025 USD
Vol Ratio (20d)0.55x

About Ion Beam Applications (EBR: IBAB)

›

Ion Beam Applications (EBR: IBAB) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 2,264 employees.

The shares were at 16.40 EUR on 20 November 2026, up 64.2% over 52 weeks. Its 52-week range is 9.990 EUR to 17.76 EUR: the price is 7.7% below the high and 64.2% above the low.

At a market capitalisation of 473.94M EUR, it trades at 19.9 times trailing earnings and 14.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.5, a discount of 22% for IBAB. It pays a dividend yielding 1.51% (it pays out 31% of its earnings), against a median of 2.35% among the dividend payers in that peer group.

Ion Beam Applications reports return on equity of 10.0%, an operating margin of 6.4% and revenue up 6.2% year over year.

Its debt exceeds its cash by 74.97M EUR, a debt-to-equity ratio of 0.92. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 17.63 EUR is 7.5% above the current price. The next earnings report is expected on 18 March 2027.